Sean Davies
-
Sean Davies awarded Scaling Success grant to develop small molecules with promise of protecting against cardiometabolic disease
Sean Davies, associate professor of pharmacology and associate director of graduate studies for the department, has been awarded a Scaling Success grant from Research Development and Support in the Office of the Vice Provost for Research and Innovation. Read MoreMar 28, 2024
-
Potential protection from atherosclerosis
Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins. Read MoreAug 19, 2021
-
‘Scavenger’ molecule may point to new atherosclerosis treatment
A small-molecule “scavenger” that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at Vanderbilt University Medical Center. Read MoreAug 20, 2020
-
New tools to study bioactive lipids
Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction. Read MoreJul 14, 2020
-
A new contributor to atherosclerosis
Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis. Read MoreJan 27, 2020
-
A probiotic treatment for obesity?
Engineered bacteria that produce beneficial compounds — and that could potentially be administered in foods like yogurt — may be a future treatment for obesity and other chronic diseases. Read MoreAug 8, 2019
-
Scavengers “protect” HDL
Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease. Read MoreJun 29, 2018
-
Inhibiting obesity
An enzyme in the gut – NAPE-PLD – is required for the action of signaling molecules that reduce food intake and weight gain. Read MoreSep 15, 2017
-
Davies lands Pharmacology teaching award
Sean Davies, Ph.D., associate professor of Pharmacology, was recognized as Pharmacology “Teacher of the Year” during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall. Read MoreMay 26, 2016
-
‘Good Cholesterol’ Levels Don’t Tell the Whole Story
High-density lipoprotein (HDL) is known as “good cholesterol” because elevated levels protect against heart attacks and plaque buildup. However, in some cases HDL may not function properly and may actually accelerate the disease. Read MoreDec 23, 2014
-
Research Roundup, Summer 2014
Private Property and Government Inaction | Probiotic Could Prevent Obesity | Freedom from Power Cords | Pickiness Doesn’t Always Pay Read MoreSep 26, 2014
-
Major grant spurs deeper look into ‘good cholesterol’
In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis. Read MoreAug 21, 2014
-
Study examines therapeutic bacteria’s ability to prevent obesity
Engineered bacteria that produce a therapeutic compound in the gut prevent obesity in mice, Vanderbilt University investigators have discovered. Read MoreJul 17, 2014